These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20932362)

  • 21. The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer.
    Zivanovic O; Eisenhauer EL; Zhou Q; Iasonos A; Sabbatini P; Sonoda Y; Abu-Rustum NR; Barakat RR; Chi DS
    Gynecol Oncol; 2008 Feb; 108(2):287-92. PubMed ID: 17996927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abdominopelvic cytoreduction rates and recurrence sites in stage IV ovarian cancer: is there a case for thoracic cytoreduction?
    Perri T; Ben-Baruch G; Kalfon S; Beiner ME; Helpman L; Hogen LB; Shapira-Frommer R; Korach J
    Gynecol Oncol; 2013 Oct; 131(1):27-31. PubMed ID: 23880152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: impact on prognosis in a single institution experience.
    Fagotti A; Vizzielli G; Fanfani F; Costantini B; Ferrandina G; Gallotta V; Gueli Alletti S; Tortorella L; Scambia G
    Gynecol Oncol; 2013 Nov; 131(2):341-6. PubMed ID: 23938372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Moving beyond "complete surgical resection" and "optimal": Is low-volume residual disease another option for primary debulking surgery?
    Manning-Geist BL; Hicks-Courant K; Gockley AA; Clark RM; Del Carmen MG; Growdon WB; Horowitz NS; Berkowitz RS; Muto MG; Worley MJ
    Gynecol Oncol; 2018 Aug; 150(2):233-238. PubMed ID: 29933927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concordance of laparoscopic and laparotomic peritoneal cancer index using a two-step surgical protocol to select patients for cytoreductive surgery in advanced ovarian cancer.
    Angeles MA; Migliorelli F; Del M; Martínez-Gómez C; Daix M; Bétrian S; Gabiache E; Balagué G; Leclerc S; Mery E; Gladieff L; Ferron G; Martinez A
    Arch Gynecol Obstet; 2021 May; 303(5):1295-1304. PubMed ID: 33389113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Long text of the Joint French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa. Part 1: Diagnostic exploration and staging, surgery, perioperative care, and pathology.
    Lavoue V; Huchon C; Akladios C; Alfonsi P; Bakrin N; Ballester M; Bendifallah S; Bolze PA; Bonnet F; Bourgin C; Chabbert-Buffet N; Collinet P; Courbiere B; De la Motte Rouge T; Devouassoux-Shisheboran M; Falandry C; Ferron G; Fournier L; Gladieff L; Golfier F; Gouy S; Guyon F; Lambaudie E; Leary A; Lecuru F; Lefrere-Belda MA; Leblanc E; Lemoine A; Narducci F; Ouldamer L; Pautier P; Planchamp F; Pouget N; Ray-Coquard I; Rousset-Jablonski C; Senechal-Davin C; Touboul C; Thomassin-Naggara I; Uzan C; You B; Daraï E
    J Gynecol Obstet Hum Reprod; 2019 Jun; 48(6):369-378. PubMed ID: 30936027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laparoscopic management of early ovarian and fallopian tube cancers: surgical and survival outcome.
    Nezhat FR; Ezzati M; Chuang L; Shamshirsaz AA; Rahaman J; Gretz H
    Am J Obstet Gynecol; 2009 Jan; 200(1):83.e1-6. PubMed ID: 19019337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MIRRORS: a prospective cohort study assessing the feasibility of robotic interval debulking surgery for advanced-stage ovarian cancer.
    Uwins C; Assalaarachchi H; Bennett K; Read J; Tailor A; Crawshaw J; Chatterjee J; Ellis P; Skene SS; Michael A; Butler-Manuel S
    Int J Gynecol Cancer; 2024 Jun; 34(6):886-897. PubMed ID: 38561194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The utility of hand-assisted laparoscopy in ovarian cancer.
    Krivak TC; Elkas JC; Rose GS; Sundborg M; Winter WE; Carlson J; MacKoul PJ
    Gynecol Oncol; 2005 Jan; 96(1):72-6. PubMed ID: 15589583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incorporating robotic surgery into the management of ovarian cancer after neoadjuvant chemotherapy.
    Abitbol J; Gotlieb W; Zeng Z; Ramanakumar A; Kessous R; Kogan L; Pare-Miron V; Rombaldi M; Salvador S; Kucukyazici B; Brin S; How J; Lau S
    Int J Gynecol Cancer; 2019 Nov; 29(9):1341-1347. PubMed ID: 31601648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials.
    Vergote I; Coens C; Nankivell M; Kristensen GB; Parmar MKB; Ehlen T; Jayson GC; Johnson N; Swart AM; Verheijen R; McCluggage WG; Perren T; Panici PB; Kenter G; Casado A; Mendiola C; Stuart G; Reed NS; Kehoe S; ;
    Lancet Oncol; 2018 Dec; 19(12):1680-1687. PubMed ID: 30413383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Residual Disease Status after Primary Cytoreductive Surgery in Patients with Advanced Ovarian, Fallopian Tube, or Peritoneal Carcinoma and Long-Term Progression-Free Survival].
    Otsuka I; Matsuura T
    Gan To Kagaku Ryoho; 2016 Dec; 43(13):2547-2551. PubMed ID: 28028263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of secondary cytoreduction for recurrent ovarian cancer by robotics, laparoscopy and laparotomy.
    Magrina JF; Cetta RL; Chang YH; Guevara G; Magtibay PM
    Gynecol Oncol; 2013 May; 129(2):336-40. PubMed ID: 23357611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laparoscopic intraperitoneal port placement for optimally cytoreduced advanced ovarian cancer.
    Janco JM; Hacker MR; Konstantinopoulos PA; Cannistra SA; Awtrey CS
    J Minim Invasive Gynecol; 2011; 18(5):629-33. PubMed ID: 21803662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiological predictors of cytoreductive outcomes in patients with advanced ovarian cancer.
    Borley J; Wilhelm-Benartzi C; Yazbek J; Williamson R; Bharwani N; Stewart V; Carson I; Hird E; McIndoe A; Farthing A; Blagden S; Ghaem-Maghami S
    BJOG; 2015 May; 122(6):843-849. PubMed ID: 25132394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206.
    Onda T; Kobayashi H; Nakanishi T; Hatae M; Iwasaka T; Konishi I; Shibata T; Fukuda H; Kamura T; Yoshikawa H
    Gynecol Oncol; 2009 Apr; 113(1):57-62. PubMed ID: 19181369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: an updated series.
    Shih KK; Chi DS; Barakat RR; Leitao MM
    Gynecol Oncol; 2010 May; 117(2):330-5. PubMed ID: 20189234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics and management of diaphragm involvement in patients with primary advanced-stage ovarian, fallopian tube, or peritoneal cancer.
    Einenkel J; Ott R; Handzel R; Braumann UD; Horn LC
    Int J Gynecol Cancer; 2009 Oct; 19(7):1288-97. PubMed ID: 19823067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Centralized primary care of advanced ovarian cancer improves complete cytoreduction and survival - A population-based cohort study.
    Dahm-Kähler P; Palmqvist C; Staf C; Holmberg E; Johannesson L
    Gynecol Oncol; 2016 Aug; 142(2):211-6. PubMed ID: 27238084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diverting ileostomy during primary debulking surgery for ovarian cancer: Associated factors and postoperative outcomes.
    Tseng JH; Suidan RS; Zivanovic O; Gardner GJ; Sonoda Y; Levine DA; Abu-Rustum NR; Tew WP; Chi DS; Long Roche K
    Gynecol Oncol; 2016 Aug; 142(2):217-24. PubMed ID: 27261325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.